The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Large Is The Fast Melt Tablets Market Projected To Become By 2030 Based On Its 2026 Valuation?
The fast melt tablets market size has experienced robust growth in recent years. It is anticipated to expand from $5.33 billion in 2025 to $5.74 billion in 2026, at a compound annual growth rate (CAGR) of 7.8%. Historically, this growth can be attributed to several factors including difficulty swallowing conventional tablets, the increasing size of pediatric and geriatric populations, early adoption in allergy and CNS drugs, a clear demand for rapid onset formulations, and the expansion of OTC fast-dissolving medicines.
The fast melt tablets market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a size of $7.73 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.7%. Factors contributing to this growth during the forecast period include a heightened emphasis on patient adherence, a rise in neurological and psychiatric conditions, the need for user-friendly drug delivery methods, increased use of medication in homecare settings, and advancements in oral thin-film technologies. Key trends expected throughout this period encompass an escalating demand for easily administered oral dosage forms, wider application in medications for children and the elderly, an increase in CNS and pain management uses, a growing inclination towards drug administration without water, and broader incorporation for travel and emergency scenarios.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23398&type=smp
What Major Growth Drivers Are Shaping The Outlook Of The Fast Melt Tablets Market?
The increasing occurrence of heart attacks is projected to fuel the expansion of the fast melt tablets market. A heart attack is an emergency condition where blood flow to the heart muscle is obstructed, typically by a blood clot or plaque accumulation in coronary arteries. This incidence is on the rise due to higher processed food consumption, which contributes to elevated cholesterol and arterial plaque. Fast melt tablets facilitate swift drug absorption, allowing for prompt delivery of essential medications like aspirin or nitroglycerin to mitigate damage during a heart attack, thereby enhancing patient results by restoring blood flow and minimizing severe complication risks. For example, in September 2025, the British Heart Foundation, a UK-based cardiovascular research charity, predicted that an additional one million people in the UK could be living with cardiovascular disease by 2030, increasing to two million more than current figures by 2040, marking an unprecedented level. Consequently, the growing frequency of heart attacks is propelling the fast melt tablets market’s growth.
What Segment Groups Are Identified Within The Fast Melt Tablets Market?
The fast melt tablets market covered in this report is segmented –
1) By Type: Anti Psychotics, Anti Epileptics, Central Nervous System (CNS) Stimulants, Anxiolytics, Anti Parkinsonian Drugs, Anti Hypertensive, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Anti Allergy Drugs, Proton Pump Inhibitors, Other Types
2) By Indication: Pain Management, Allergy And Respiratory Disorders, Neurological Disorders, Gastrointestinal Disorders, Cardiovascular Disorders, Other Indications
3) By Dosage Form: Oral, Sublingual, Buccal, Chewable
4) By Age Group: Adult, Pediatrics, Geriatrics
5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies
Subsegments:
1) By Anti Psychotics: Atypical Antipsychotics, Typical Antipsychotics
2) By Anti Epileptics: Sodium Channel Blockers, Gamma-Aminobutyric Acid (GABA) Analogs
3) By Central Nervous System (CNS) Stimulants: Amphetamines, Methylphenidate, Modafinil
4) By Anxiolytics: Benzodiazepines, Azapirones, Antihistamines
5) By Anti Parkinsonian Drugs: Dopamine Agonists, Monoamine Oxidase-B (MAO-B) Inhibitors, Anticholinergics
6) By Anti Hypertensive: Beta Blockers, Calcium Channel Blockers
7) By Non-Steroidal Anti-Inflammatory Drugs (NSAIDS): Cyclooxygenase-1 (COX-1) Inhibitors
8) By Anti Allergy Drugs: Antihistamines, Leukotriene Receptor Antagonists
9) By Proton Pump Inhibitors: Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole
10) By Other Types: Antiemetics, Antidepressants, Analgesics
What Trends Are Advancing Progress In The Fast Melt Tablets Market?
Major companies operating in the fast melt tablets market are concentrating on innovative formulations, such as orally disintegrating tablet (ODT) technologies, which facilitate rapid dissolution without water to boost medication adherence, convenience, and accessibility for patients dealing with chronic neurological conditions. Orally Disintegrating Tablet (ODT) Technology enables the delivery of active ingredients via a fast-melt format that dissolves on the tongue within seconds, offering ease of administration for patients who find swallowing traditional tablets difficult or who need discreet, portable dosing solutions. For example, in February 2023, Cycle Pharmaceuticals Ltd., a U.K.-based rare disease and specialty pharmaceuticals company, launched TASCENSO ODT (fingolimod), which is the first FDA-approved orally disintegrating tablet for treating relapsing forms of multiple sclerosis (MS) in patients aged 10 years and older. Developed using Catalent’s ZYDIS fast-dissolve platform, this bioequivalent non-generic ODT ensures continuity of care for U.S. patients losing access to Gilenya support services and is further supported by Cycle’s dedicated patient platform, Cycle Vita, which offers co-pay assistance, bridge programs, and in-home baseline assessments to maintain uninterrupted fingolimod therapy.
Which Companies Hold Significant Positions In The Fast Melt Tablets Market?
Major companies operating in the fast melt tablets market are Pfizer Inc., Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Unichem Laboratories Ltd., Lannett Company Inc., Perrigo Company plc, Catalent Inc., SPI Pharma Inc., Fuji Chemical Industries Co. Ltd., Melt Pharmaceuticals Inc., Akina Inc., Church & Dwight Co. Inc., Windmill Health Products LLC, The Procter & Gamble Company, Hikma Pharmaceuticals plc, Dr. Reddy’s Laboratories Ltd.
Read the full fast melt tablets market report here:
https://www.thebusinessresearchcompany.com/report/fast-melt-tablets-global-market-report
Which Regions Are Projected To Dominate The Fast Melt Tablets Market In The Coming Years?
North America was the largest region in the fast melt tablets market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fast melt tablets market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Fast Melt Tablets Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=23398&type=smp
Browse Through More Reports Similar to the Global Fast Melt Tablets Market 2026, By The Business Research Company
Tablets Market Report 2026
https://www.thebusinessresearchcompany.com/report/tablets-global-market-report
Effervescent Tablet Market Report 2026
https://www.thebusinessresearchcompany.com/report/effervescent-tablet-global-market-report
Hot Melt Based Adhesives Market Report 2026
https://www.thebusinessresearchcompany.com/report/hot-melt-based-adhesives-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model